PALM BEACH, Florida, November 9, 2017 /PRNewswire/ --
A constant and continued growth of legal cannabis throughout North America is leading to expanded operations and production of new products, as well as solid stock performance as the industry continues to earn lofty revenue forecasts from analysts. ArcView, a leading research group for the legal marijuana industry, recently reported legal cannabis, hemp and marijuana sales soared in North America by 34% last year, and they're slated to grow by an average of 26% annually through 2021. That type of growth appears to be enough to attract investors to marijuana stocks such as: MYM Nutraceuticals Inc. (OTC: MYMMF) (CSE: MYM), Canopy Growth Corporation (TSX: WEED) (OTC: TWMJF), Aurora Cannabis Inc. (TSX: ACB) (OTC: ACBFF), Medical Marijuana, Inc. (OTC: MJNA), Terra Tech Corp. (OTC: TRTC).
MYM Nutraceuticals Inc. (OTCQB: MYMMF) (CSE: MYM.CN) is pleased to announce that the Laval Project is on schedule for completion on December 15th, 2017. MYM will then be submitting on confirmation of readiness video and Standard Operating Procedures for Cultivation to Health Canada. All underground plumbing is complete, HVAC installation is underway and next week the storage vault will be completed. All the walls of the production rooms are insulated and have the bullet proof windows installed. MYM has completed the grow equipment purchase order and was able to cut the projected costs in half. Grow equipment will arrive in 10 days to be installed. Read this and more news for MYM Nutraceuticals at: http://www.marketnewsupdates.com/news/mymmf.html
In parallel, MYM's mega project 'Weedon' has been progressing rapidly with engineering land studies completed and the Health Canada application is progressing rapidly. The Weedon processing and packaging, distribution plant design has been completed and final implementation on the greenhouse design of the first phase of 300,000 sqft is close to completion. MYM is currently going through the process to acquire a 'Distribution and Dealers Import Export license' application with Health Canada, which will open up worldwide markets for MYM.
"Demand for cannabis is growing worldwide and with MYM actively investigating all opportunities in each sector of the cannabis industry, it will develop MYM into a complete Global seed-to-sale company," said Rob Gietl, Chief Executive Officer. "MYM is working to open up cannabis distribution channels globally to accelerate our growth. Our Weedon project alone has 329 acres to expand production on. As recreational cannabis opens in more markets and as global markets expand; we plan on being ahead of the curve and have supply chains ready."
In other industry news of note:
Canopy Growth Corporation (TSX: WEED.TO) (OTC: TWMJF) and Delta 9 Cannabis Inc. (TSX.V: NINE) ('Delta 9' or together, the 'Companies') applaud the framework this week announced by the Province of Manitoba regarding adult-use cannabis production, distribution, and retail. The decision by the Government of Manitoba to allow for private retail distribution of cannabis while ensuring that public safety and health concerns are the focal points of its cannabis policies is a strong and welcomed approach. As responsible existing cannabis businesses, Delta 9 and Canopy Growth plan to work collaboratively within the proposed Manitoba framework to bring locally produced products as well as the best variety from across the country to future cannabis consumers throughout the province.
Aurora Cannabis Inc. (TSX: ACB.TO) (OTCQX: ACBFF) announced this week that the Company has elected to exercise its right under the indenture (the 'Indenture') governing the Company's 8.0% unsecured convertible debentures due November 1, 2018 (the 'Debentures') to convert (the 'Conversion') all of the principal amount outstanding of the remaining Debentures and unpaid accrued interest thereon up to December 9, 2017 into common shares of the Company (the 'Common Shares'). Pursuant to the terms of the Indenture, the Company may force the conversion of the Debentures at the conversion price of $2.00 per Common Share when the VWAP of the Common Shares on the TSX Exchange (the 'Exchange') for 10 consecutive trading days equals or exceeds $3.00.
Medical Marijuana, Inc. (OTC: MJNA) announced yesterday that subsidiary Kannaway, LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, has introduced Kannaway® SuperGreens, a brand new way to take advantage of hemp's nutritional benefits. Kannaway® SuperGreens is formulated with more than 40 different superfood and nutrient dense ingredients, Kannaway® SuperGreens makes it easier to get the suggested daily intake of vitamins, minerals, fiber, protein, and other nutrients by using products such as wheat, barley, and alfalfa grasses, spinach, broccoli, kale, acai, carrot, beet, turmeric, flax and chia seeds, hemp flour, and Kannaway's exclusive Bi-Bong® herbal extracts.
Terra Tech Corp. (OTCQX: TRTC), a vertically integrated, cannabis-focused agriculture company, will release its Third Quarter 2017 results today - Thursday, November 9, 2017 after U.S. markets close. The company will also host a conference call on Thursday, November 9, 2017 at 4:30 PM Eastern.
- Dial-In Number: 1-857-232-0157
- Access Code: 422095
- Derek Peterson, Chairman and CEO of Terra Tech Corp., will be answering shareholder questions at the end of the call.
DISCLAIMER: MarketNewsUpdates.com (MNU) is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. MNU is NOT affiliated in any manner with any company mentioned herein. MNU and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. MNU's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. MNU is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed MNU has been compensated forty four hundred dollars for news coverage of the current press release issued by MYM Nutraceuticals Inc. by a non-affiliated third party. MNU HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and MNU undertakes no obligation to update such statements.